Stay updated on nickel market trends, EU's Critical Raw Materials Act projects, Indonesian royalties, and global company ...

A key drug in this class, semaglutide is set to go off-patent in March next year, and several Indian players, including Mankind Pharma Limited, Alkem Labs Limited, and Dr. Reddy’s Laboratories ...

Management reaffirmed the fiscal 2025 midpoint guidance for organic ASV growth at 5%, with a narrowed growth range reflecting 4.4% to 5.8%. Revenue guidance was adjusted to $2.305 billion to $2. ...

The life sciences sector accounted for 49.3% of total investment in Pittsburgh’s tech economy last year, followed by software and hardware, which collectively represented 22.9% and 26.84%, ...

Elon Musk reported a significant cyberattack on X, potentially by a coordinated group or nation. Nikesh Arora, CEO of Palo Alto Networks, has offered assistance. Pro-Palestinian group Dark Storm ...

Sun Pharmaceutical Industries has agreed to acquire US-based cancer drug maker in a deal valued at $355 million in upfront cash payment, India’s biggest pharma ... Big Tech leads US stock ...

Eight tech titans have taken a $266 billion blow to their collective wealth this year. Their combined net worth fell by $64 billion on Monday as the Nasdaq had its worst day since 2022.

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

This strategic move will add Checkpoint’s FDA-approved skin cancer treatment, UNLOXCYT (cosibelimab-ipdl), to Sun Pharma’s global onco-derm franchise. UNLOXCYT is the first and only FDA-approved ...